Valerio Therapeutics Société anonyme (EPA:ALVIO)
France · Delayed Price · Currency is EUR 0.6900
-0.0160 (-2.27%)
Sep 11, 2026, 5:35 PM CET
EPA:ALVIO Market Cap
EPA:ALVIO has a market cap or net worth of €344.62 million as of September 11, 2026. Its market cap has increased by 3,063.94% in one year.
Market Cap
344.62M
Enterprise Value
351.88M
Revenue
2.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.69
ChartMarket Cap Chart
Since December 8, 2005, EPA:ALVIO's market cap has increased from 72.77M to 344.62M, an increase of 373.58%. That is a compound annual growth rate of 7.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 344.62M | 410.84% |
| Dec 31, 2025 | 67.46M | 484.18% |
| Dec 31, 2024 | 11.55M | -54.58% |
| Dec 29, 2023 | 25.42M | 62.58% |
| Dec 30, 2022 | 15.64M | -59.41% |
| Dec 31, 2021 | 38.52M | -25.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nanobiotix | 1.59B |
| Inventiva | 803.35M |
| MedinCell | 781.44M |
| Genfit | 651.32M |
| DBV Technologies | 620.83M |
| Valneva SE | 547.70M |
| Transgene | 241.29M |
| Cellectis | 191.49M |